Study Objective {#sec1}
===============

Current laboratory algorithms for diagnosis of respiratory viral infections can be time consuming, and are ill-suited for informing isolation and treatment decisions in the emergency department (ED). A novel molecular testing method employs electrospray ionization mass spectrometry (ESI-MS) to characterize base compositions of pathogen nucleic acids amplified via RT-PCR and permits viral identification and characterization within 8 hours of sample collection. The objective of this study was to investigate the performance characteristics of RT-PCR/ESI-MS as a rapid detection platform for respiratory viruses in patients with suspected respiratory infections.

Methods {#sec2}
=======

In this prospective case series, a convenience sample of nasopharyngeal swabs were collected from patients presenting with influenza-like illness in a tertiary care hospital ED between December 2010 and March 2011. Samples were processed by the clinical virology laboratory\'s algorithm of direct fluorescence antigen (DFA) assay followed by the Luminex Respiratory Viral Panel Assay for standard of care. 300 μl of sample was also aliquoted and processed by RT-PCR/ESI-MS using broad-range primers designed for respiratory virus detection. RT-PCR/ESI-MS results were compared with clinical virology results, and confidence intervals for sensitivity and specificity were based on binomial distribution curves.

Results {#sec3}
=======

Thirty-six nasopharyngeal swabs have been collected to date; 11 were positive by direct fluorescence antigen/respiratory viral panel for viral pathogens and 25 were negative. Interim assay performance for the 36 nasopharyngeal swabs was 90.9% sensitivity (95% CI: 57.1-99.5) and 96.0% specificity (95% CI: 77.7-99.8). Pathogens identified included 5 respiratory syncytial viruses, 2 human metapneumoviruses, 1 influenza A virus, 1 influenza B virus, and 1 coronavirus. 1 human metapneumovirus sample was missed by the assay but detected by respiratory viral panel. Notably, 5/11 (45.5%) of viral positive samples were negative by direct fluorescence antigen but positive by both RT-PCR/ESI-MS and Luminex respiratory viral panel. RT-PCR/ESI-MS processing time from sample collection to result was 8 hours as opposed to standard clinical virology protocols, which required up to 24 hours.

Conclusion {#sec4}
==========

Preliminary results demonstrate that RT-PCR/ESI-MS platform is a sensitive and specific detector of respiratory viral pathogens in nasopharngeal swabs, and has added diagnostic utility over traditional laboratory algorithms. Turnaround time is moderately rapid versus standard clinical protocols. Further study is required to determine clinical utility in ED practice.
